Yong Man Kim
No más puestos en curso
Fortuna: 56 200 $ al 30/04/2024
Perfil
Dr. Yong Man Kim is a Chief Scientific Officer & Director at NKMAX Co., Ltd.
and a Director & Chief Scientific Officer at NKGen Biotech, Inc. He is on the Board of Directors at NKMAX Co., Ltd.
and NKGen Biotech, Inc. Dr. Kim was previously employed as a Chief Scientific & Innovation Officer by NKGen Biotech, Inc. /US/ and a Research Professor by Wonkwang University.
He received his doctorate degree from Chungnam National University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0.12% | 29/04/2024 | 28 384 ( 0.12% ) | 56 200 $ | 30/04/2024 |
Cargos activos de Yong Man Kim
| Empresas | Cargo | Inicio |
|---|---|---|
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Director Técnico/Científico/I+D | 01/09/2017 |
Antiguos cargos conocidos de Yong Man Kim.
| Empresas | Cargo | Fin |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Director Técnico/Científico/I+D | 01/09/2023 |
| Wonkwang University | Corporate Officer/Principal | - |
Formación de Yong Man Kim.
| Chungnam National University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Yong Man Kim
